Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Utility of Targeted Neurocognitive Testing in Detecting Early Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) after CAR T-Cell Therapy

Arvind Suresh, Maeen N. Arslan, Heather A. Wishart, Amy M. Chan, Bryce S. Jacobson, Grant Moncrief, Christopher H. Lowrey, Christi Ann Hayes, Susan C. Brighton, Dorothy R. McKenna, Lisa J. Wesinger, Judi A. Gentes, Kate L. Caldon, Zbigniew M. Szczepiorkowski, Kenneth R. Meehan, John M. Hill, Jr.

Blood (2022) 140 (Supplement 1): 4686–4687.

https://doi.org/10.1182/blood-2022-168112

Published: 2022

Journal Articles

Patient Reported Outcomes for Patients Receiving a Hematopoietic Stem Cell Transplant: A Longitudinal Assessment with a Dashboard Display

Christi Ann Hayes, Kenneth R. Meehan, Elizabeth A O'Donnell, Aricca Van Citters, Kate L. Caldon, Charlotte M Coughenour, Dorothy R. McKenna, Carla Tarzia, Wenyan Zhao, Kimberley R Holt, Christopher H. Lowrey, John M. Hill, Jr., Tiffany D'Cruze, Megan M Holthoff, Tor Tosteson, Anna Tosteson

Blood (2022) 140 (Supplement 1): 8113–8114.

https://doi.org/10.1182/blood-2022-163437

Published: 2022

Journal Articles

Non-Relapse Mortality and Quality of Life with Shared Care after Allogeneic Hematopoietic Cell Transplantation: A Randomized Control Trial

Blood (2022) 140 (Supplement 1): 2135–2136.

https://doi.org/10.1182/blood-2022-166996

Published: 2022

Journal Articles

Trends in allogeneic stem cell transplantation for multiple myeloma: a CIBMTR analysis

Blood (2011) 118 (7): 1979–1988.

https://doi.org/10.1182/blood-2011-02-337329

Published: 2011

Journal Articles

Peripheral Blood Chimerism Can Replace Marrow Chimerism Analyses Following Adult Allogeneic Stem Cell Transplant.

Cocav Rauwerdink, MD, Gregory J Tsongalis, PhD, John M. Hill, Jr., MD, Kenneth R Meehan, MD

Blood (2009) 114 (22): 4316.

https://doi.org/10.1182/blood.V114.22.4316.4316

Published: 2009

Journal Articles

Distance From a Tertiary Care Center Is Not a Barrier to Transplant for Patients with Myeloma.

Brea C. Lipe, MD, Christopher R Russo, Jiang Gui, Kenneth R Meehan, MD

Blood (2009) 114 (22): 4366.

https://doi.org/10.1182/blood.V114.22.4366.4366

Published: 2009

Journal Articles

The Critical Requirement of the NKG2D Receptor On CD8+ T Cells in Killing Myeloma Cells.

Laleh X. Talebian, PhD, Dawn A Fischer, BS, Zbigniew M Szczepiorkowski, MD, PhD, FCAP, Charles L Sentman, MD, Kenneth R Meehan, MD

Blood (2009) 114 (22): 4733.

https://doi.org/10.1182/blood.V114.22.4733.4733

Published: 2009

Journal Articles

Immune Mobilization with IL-2 and Growth Factors: Differential in Vivo Effects of the NKG2D Receptor on CD8+ and CD56+ Effector Cells

Kenneth R Meehan, MD, John M. Hill, Jr., MD, Marc Ernstoff, MD, Charles L Sentman, MD

Blood (2008) 112 (11): 3491.

https://doi.org/10.1182/blood.V112.11.3491.3491

Published: 2008

Journal Articles

Immune Mobilization with Direct In-Vivo Effector Response: Clinical Trial with Favorable Implications for Post-Transplant Outcome.

John M. Hill, MD, Jia-Yan Wu, PhD, Susan M. Webber, Lynn D. Root, Elizabeth A. Kimtis, Idalina C. Williams, Marc S. Ernstoff, MD, Zbigniew M. Szczepiorkowski, MD, Charles L. Sentman, PhD, Kenneth R. Meehan, MD

Blood (2007) 110 (11): 5120.

https://doi.org/10.1182/blood.V110.11.5120.5120

Published: 2007

Journal Articles

Transplantation in the Elderly: The Affect of Age on Clinical Course and Outcomes.

Marcy Canary, MD, John M. Hill, MD, Kenneth R. Meehan, MD

Blood (2007) 110 (11): 5114.

https://doi.org/10.1182/blood.V110.11.5114.5114

Published: 2007

Journal Articles

Large Scale Expansion of Activated T Cells: Defining Procedures and Cryopreservation Methods for Clinical Use as Adoptive Cellular Therapy Post-Transplant.

Jia-Yan Wu, PhD, Susan M. Webber, BS MT(ASAP) BB, John M. Hill, MD, Marc Ernstoff, MD, Zbigniew Szczepiorkowski, MD, PhD, Kenneth R. Meehan, MD

Blood (2006) 108 (11): 5232.

https://doi.org/10.1182/blood.V108.11.5232.5232

Published: 2006

Journal Articles

Immune Mobilization of Autologous Peripheral Blood Progenitor Cells: IL-2 with GM-CSF and G-CSF Results in Effective Mobilization without Delay in Engraftment.

John M. Hill, MD, Jia-Yan Wu, PhD, Susan M. Webber, BS, MT(ASAP), BB, Ortal Sharlin, Melinda Kendall, David McGregor, MT(ASCP), Marc J. Ernstoff, MD, Zbigniew M. Szczepiorkowski, MD, PhD, Kenneth R. Meehan, MD

Blood (2006) 108 (11): 5152.

https://doi.org/10.1182/blood.V108.11.5152.5152

Published: 2006

Journal Articles

Synergistic Effects of Bortezomib with Low Dose Melphalan Against Human AML Cells.

Marc Gautier, MD, Jeffrey A. Bubis, DO, Jia-Yan Wu, Ph.D, Kenneth R. Meehan, MD

Blood (2005) 106 (11): 4463.

https://doi.org/10.1182/blood.V106.11.4463.4463

Published: 2005

Journal Articles

Pilot Study of Low Dose Melphalan and Bortezomib for Treatment of Acute Myelogenous Leukemia and High-Risk Myelodysplastic Syndromes.

Jeffrey A. Bubis, DO, Pamela Ely, MD, PhD, Kenneth R. Meehan, MD, Diane Stearns, ARNP, Anna D. Schaal, ARNP, Elizabeth A. Kimtis, ARNP, Christopher Lowrey, MD, Elizabeth M. Bengtson, MD, John Hill, MD, Marc Gautier, MD

Blood (2005) 106 (11): 4633.

https://doi.org/10.1182/blood.V106.11.4633.4633

Published: 2005

Journal Articles

Successful PBSC Mobilization, Collection, Transplantation and Engraftment after Radioimmunotherapy with Yttrium-90 Ibritumomab Tiuxetan for Non-Hodgkin’s Lymphoma (NHL).

Pamela Ely, MD, PhD, Diane M. Stearns, ARNP, Bassem I. Zaki, MD, Thomas F. Fitzmaurice, Ph.D, Marc Gautier, MD, Christopher H. Lowrey, MD, Elizabeth M. Bengtson, MD, John M. Hill, MD, Anna D. Schaal, ARNP, Elizabeth A. Kimtis, ARNP, Lynn Root, RN, Susan Webber, MT (ASCP), BB, Zbigniew M. Szczepiorkowski, MD, Ph.D, Kenneth R. Meehan, MD

Blood (2005) 106 (11): 5517.

https://doi.org/10.1182/blood.V106.11.5517.5517

Published: 2005

Journal Articles

The Use of a Bone Marrow Transplant Program Public Website for Patient Education and Reporting of Outcomes: Increased Use Resulting in Improved Patients’ Trust and Assurance.

Elissa F. Malcolm, MS, Linda J. Patchett, RN, MBA, Thomas F. Fitzmaurice, Ph.D, John M. Hill, MD, Kenneth R. Meehan, MD

Blood (2005) 106 (11): 5592.

https://doi.org/10.1182/blood.V106.11.5592.5592

Published: 2005

Journal Articles

The Critical Role of the NKG2D Receptor in CD8+CTL and CD8+CD56+ NKT Cell Cytotoxicity.

Jia-Yan Wu, Ph.D, John M. Hill, MD, Marc Ernstoff, MD, Kenneth R. Meehan

Blood (2004) 104 (11): 3164.

https://doi.org/10.1182/blood.V104.11.3164.3164

Published: 2004

Journal Articles

Resource Utilization, Costs and Type of Malignancy Associated with Prolonged Length of Stay in Autologous Stem Cell Recipients.

Linda J. Patchett, RN, MBA, John M. Hill, MD, Thomas F. Fitzmaurice, Ph.D, Kenneth R. Meehan, MD

Blood (2004) 104 (11): 5311.

https://doi.org/10.1182/blood.V104.11.5311.5311

Published: 2004

NARROW

Utility of Targeted Neurocognitive Testing in Detecting Early Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) after CAR T-Cell Therapy

Patient Reported Outcomes for Patients Receiving a Hematopoietic Stem Cell Transplant: A Longitudinal Assessment with a Dashboard Display

Non-Relapse Mortality and Quality of Life with Shared Care after Allogeneic Hematopoietic Cell Transplantation: A Randomized Control Trial

Trends in allogeneic stem cell transplantation for multiple myeloma: a CIBMTR analysis

Peripheral Blood Chimerism Can Replace Marrow Chimerism Analyses Following Adult Allogeneic Stem Cell Transplant.

Distance From a Tertiary Care Center Is Not a Barrier to Transplant for Patients with Myeloma.

The Critical Requirement of the NKG2D Receptor On CD8+ T Cells in Killing Myeloma Cells.

Immune Mobilization with IL-2 and Growth Factors: Differential in Vivo Effects of the NKG2D Receptor on CD8+ and CD56+ Effector Cells

Immune Mobilization with Direct In-Vivo Effector Response: Clinical Trial with Favorable Implications for Post-Transplant Outcome.

Transplantation in the Elderly: The Affect of Age on Clinical Course and Outcomes.

Large Scale Expansion of Activated T Cells: Defining Procedures and Cryopreservation Methods for Clinical Use as Adoptive Cellular Therapy Post-Transplant.

Immune Mobilization of Autologous Peripheral Blood Progenitor Cells: IL-2 with GM-CSF and G-CSF Results in Effective Mobilization without Delay in Engraftment.

Synergistic Effects of Bortezomib with Low Dose Melphalan Against Human AML Cells.

Pilot Study of Low Dose Melphalan and Bortezomib for Treatment of Acute Myelogenous Leukemia and High-Risk Myelodysplastic Syndromes.

Successful PBSC Mobilization, Collection, Transplantation and Engraftment after Radioimmunotherapy with Yttrium-90 Ibritumomab Tiuxetan for Non-Hodgkin’s Lymphoma (NHL).

The Use of a Bone Marrow Transplant Program Public Website for Patient Education and Reporting of Outcomes: Increased Use Resulting in Improved Patients’ Trust and Assurance.

The Critical Role of the NKG2D Receptor in CD8+CTL and CD8+CD56+ NKT Cell Cytotoxicity.

Resource Utilization, Costs and Type of Malignancy Associated with Prolonged Length of Stay in Autologous Stem Cell Recipients.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only